January 2023 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in January 2023 for investigational products in development.
The table provided is a review of notable updates that occurred in January 2023 for investigational products in development.
The randomized, double-blind, multicenter PHALCON-NERD-301 study included 776 adults with symptomatic NERD.
The FDA has established an acceptable daily intake limit for NVP of 96ng/day.
Protection against aspirin-associated peptic ulcer bleeding in older adults lost after the first 2.5 years
Konvomep contains 2mg of omeprazole, a proton pump inhibitor, and 84mg of sodium bicarbonate per mL after reconstitution.
The Simplist ready-to-administer prefilled syringes minimize preparation steps for clinicians.
The recalled lots were distributed to Major Pharmaceuticals Distribution Center between July 1, 2020 and October 31, 2021.
Stay up-to-date on the latest drugs in development.
Perrigo received final approval to manufacture Omeprazole Magnesium Delayed-Release Mini Capsules, 20mg.
Vonoprazan is an oral small molecule potassium-competitive acid blocker.